Commit To Buy Enanta Pharmaceuticals At $32, Earn 40.7% Annualized Using Options
October 02, 2015 at 11:41 AM EDT
Investors eyeing a purchase of Enanta Pharmaceuticals, Inc. (ENTA) stock, but tentative about paying the going market price of $37.30/share, might benefit from considering selling puts among the alternative strategies at their disposal..